Location History:
- Groton, CT (US) (2009)
- Thousand Oaks, CA (US) (2013)
Company Filing History:
Years Active: 2009-2013
Title: The Innovative Contributions of John A. Vanecko
Introduction
John A. Vanecko is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. With a total of two patents to his name, Vanecko's work focuses on the design of purine-core inhibitors and their applications in oncology.
Latest Patents
Vanecko's latest patents include "Purine-core inhibitors of HSP90 and their use in treating cancer." This invention relates to compounds of specific formulae that target cancer cells effectively. The compounds are characterized by various substituents, including aryl and heteroaryl groups, which enhance their therapeutic potential. Another significant patent is "Therapeutic compounds and their use in cancer," which also involves compounds of a defined formula aimed at treating cancer. These inventions highlight Vanecko's commitment to advancing cancer therapies through innovative chemical design.
Career Highlights
Throughout his career, John A. Vanecko has worked with prominent companies in the pharmaceutical industry. He has been associated with Myriad Pharmaceuticals, Inc. and Myrexis, Inc., where he contributed to the development of groundbreaking cancer treatments. His expertise in medicinal chemistry and drug design has positioned him as a valuable asset in the field.
Collaborations
Vanecko has collaborated with several talented individuals in his
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.